Palvella Therapeutics, Inc. · NASDAQ:PVLA

Kiritsy Christopher P sold 313 Palvella Therapeutics, Inc. shares (Form 4)

Traded Sep 2, 2026 · Filed Sep 4, 2026

On Sep 2, 2026, Kiritsy Christopher P (Director) sold 313 Palvella Therapeutics, Inc. shares at US$157.00 for US$49,141, leaving 250 shares. Filed Sep 4, 2026 (Form 4).

Sold
313 shares
Price
US$157.00
Value
US$49,141
Holding after
250 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026Common StockOption exercise313US$127.20563Direct
Sep 2, 2026Common StockSale313US$157.00250Direct

Source

View original at SEC

Related